SG136882A1 - Use of an anti-atherothrombotic compound in obtaining medicaments intended for the treatment of vascular disorders - Google Patents

Use of an anti-atherothrombotic compound in obtaining medicaments intended for the treatment of vascular disorders

Info

Publication number
SG136882A1
SG136882A1 SG200702553-9A SG2007025539A SG136882A1 SG 136882 A1 SG136882 A1 SG 136882A1 SG 2007025539 A SG2007025539 A SG 2007025539A SG 136882 A1 SG136882 A1 SG 136882A1
Authority
SG
Singapore
Prior art keywords
atherothrombotic
compound
treatment
vascular disorders
medicaments intended
Prior art date
Application number
SG200702553-9A
Other languages
English (en)
Inventor
Marie-Dominique Fratacci
Agnes De Cordoue
Laurence Lerond
Tony Verbeuren
Alain Rupin
Gilbert Lavielle
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of SG136882A1 publication Critical patent/SG136882A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG200702553-9A 2006-04-07 2007-04-05 Use of an anti-atherothrombotic compound in obtaining medicaments intended for the treatment of vascular disorders SG136882A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0603082A FR2899473B1 (fr) 2006-04-07 2006-04-07 Utilisation d'un compose anti-atherothrombotique pour l'obtention de medicaments destines au traitement des troubles vasculaires

Publications (1)

Publication Number Publication Date
SG136882A1 true SG136882A1 (en) 2007-11-29

Family

ID=37084627

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200702553-9A SG136882A1 (en) 2006-04-07 2007-04-05 Use of an anti-atherothrombotic compound in obtaining medicaments intended for the treatment of vascular disorders

Country Status (40)

Country Link
US (1) US20070238785A1 (de)
EP (2) EP1842537B1 (de)
JP (1) JP2009532447A (de)
KR (2) KR20070100658A (de)
CN (2) CN101049292A (de)
AP (1) AP2007003952A0 (de)
AR (1) AR060288A1 (de)
AT (1) ATE452633T1 (de)
AU (1) AU2007201525A1 (de)
BR (1) BRPI0701597A (de)
CA (1) CA2582394A1 (de)
CO (1) CO5820217A1 (de)
CR (1) CR9020A (de)
CY (1) CY1109793T1 (de)
DE (1) DE602007003880D1 (de)
DK (1) DK1842537T3 (de)
EA (1) EA013874B1 (de)
ES (1) ES2338600T3 (de)
FR (1) FR2899473B1 (de)
GE (1) GEP20094782B (de)
GT (1) GT200700029A (de)
HR (1) HRP20100091T1 (de)
IL (1) IL182406A0 (de)
MA (1) MA28988B1 (de)
MX (1) MX2007004108A (de)
NI (1) NI200700083A (de)
NO (1) NO20071833L (de)
NZ (1) NZ554348A (de)
PE (1) PE20071147A1 (de)
PL (1) PL1842537T3 (de)
PT (1) PT1842537E (de)
RS (1) RS51207B (de)
SG (1) SG136882A1 (de)
SI (1) SI1842537T1 (de)
SV (1) SV2008003053A (de)
TN (1) TNSN07117A1 (de)
TW (1) TW200808306A (de)
UY (1) UY30263A1 (de)
WO (1) WO2007116138A1 (de)
ZA (1) ZA200702866B (de)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9102862D0 (en) * 1991-02-11 1991-03-27 Erba Carlo Spa N-imidazolyl derivatives of substituted or alkoxymino tetrahydronaphthalenes and chromans
RU2120292C1 (ru) * 1992-07-22 1998-10-20 Российско-германское акционерное общество закрытого типа "УТИЛЕКС" Способ лечения мозговых сосудистых кризов
FR2711139B1 (fr) * 1993-10-15 1995-12-01 Adir Nouveaux dérivés de 1,2,3,4-tétrahydronaphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
DE4343776A1 (de) * 1993-12-17 1995-06-22 Schering Ag Cyclopentanonderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
JPH08119936A (ja) * 1994-10-18 1996-05-14 Fujisawa Pharmaceut Co Ltd 複素環式誘導体
FR2805261A1 (fr) * 2000-02-18 2001-08-24 Adir Nouveaux derives d'acides 6-amino ou 6-hydrazinosulfonyl-3- quinolinyl phosphoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2857593B1 (fr) * 2003-07-18 2005-10-14 Servier Lab Composition pharmaceutique orodispersible d'un compose antithrombotique
FR2860436B1 (fr) * 2003-10-03 2006-01-20 Servier Lab Nouvelle association d'un anti-atherothrombotique et d'un antiagregant plaquettaire

Also Published As

Publication number Publication date
ZA200702866B (en) 2008-07-30
NZ554348A (en) 2008-09-26
HRP20100091T1 (hr) 2010-04-30
FR2899473B1 (fr) 2008-06-13
CR9020A (es) 2008-09-23
UY30263A1 (es) 2007-05-31
ES2338600T3 (es) 2010-05-10
NO20071833L (no) 2007-10-08
AR060288A1 (es) 2008-06-04
AP2007003952A0 (en) 2007-04-30
DK1842537T3 (da) 2010-04-12
SV2008003053A (es) 2009-12-02
EA200700573A2 (ru) 2007-10-26
PT1842537E (pt) 2010-01-15
DE602007003880D1 (de) 2010-02-04
MX2007004108A (es) 2009-02-16
CO5820217A1 (es) 2007-11-30
CN101693025A (zh) 2010-04-14
GT200700029A (es) 2007-10-31
KR20070100658A (ko) 2007-10-11
MA28988B1 (fr) 2007-11-01
TW200808306A (en) 2008-02-16
GEP20094782B (en) 2009-09-25
NI200700083A (es) 2008-06-09
WO2007116138A1 (fr) 2007-10-18
SI1842537T1 (sl) 2010-03-31
TNSN07117A1 (fr) 2008-06-02
IL182406A0 (en) 2008-01-20
ATE452633T1 (de) 2010-01-15
CA2582394A1 (fr) 2007-10-07
PL1842537T3 (pl) 2010-06-30
AU2007201525A1 (en) 2007-10-25
BRPI0701597A (pt) 2007-12-11
EA013874B1 (ru) 2010-08-30
EP1842537A1 (de) 2007-10-10
PE20071147A1 (es) 2007-12-22
RS51207B (sr) 2010-12-31
CN101049292A (zh) 2007-10-10
JP2009532447A (ja) 2009-09-10
US20070238785A1 (en) 2007-10-11
FR2899473A1 (fr) 2007-10-12
EP1842537B1 (de) 2009-12-23
KR20090086500A (ko) 2009-08-13
EP2105132A1 (de) 2009-09-30
EA200700573A3 (ru) 2007-12-28
CY1109793T1 (el) 2014-09-10

Similar Documents

Publication Publication Date Title
GB2453188B (en) Use of compounds in the manufacture of medicaments for treatment of regional fat deposits
EP2166837A4 (de) Wirkstoffkombination zur behandlung von hauterkrankungen
IL184425A0 (en) Cxcr4 antagonists for the treatment of medical disorders
PL2001466T3 (pl) Rapamycyna w małej dawce do leczenia chorób związanych z przepuszczalnością naczyń
IL192299A0 (en) Use of nitrooxyderivative of drug for the treatment of muscular dystrophies
IL193747A0 (en) New therapeutic combinations for the treatment of depression
IL202515A (en) Thyroid-like compounds and their use in the preparation of drugs for the treatment of @ metabolic diseases
SI2056842T1 (sl) Modificiran galaktosil-ceramid za zdravljenje kancerogenih obolenj
HUE037109T2 (hu) Endoxifén rák kezelésében történõ alkalmazásra
IL191832A0 (en) Pyridiazinone derivatives for the treatment of tumours
IL182407A0 (en) Use of agomelating in obtaining medicaments intended for the treatment of generalized anxiety disorder
SI2234631T1 (sl) Spojine in postopki za zdravljenje ĺ˝ilne bolezni
GB0715790D0 (en) Drug combination for the treatment of sialorrhoea
IL193799A0 (en) New therapeutic combinations for the treatment or prevention of psycotic disorders
IL199214A0 (en) New combination for use in the treatment of inflammatory disorders
IL186022A0 (en) Dermatological compositions and salts for the treatment of dermatological diseases
PL1982178T3 (pl) Sposoby leczenia zaburzeń afektywnych
IL192933A0 (en) Benzoisoindole derivatives for the treatment of pain
ZA200806949B (en) Medicinal formulation for the treatment for hepatitis C
GB0710277D0 (en) Use of antivirals in the treatment of medical disorders
PL2307380T3 (pl) Pochodne N’-nitroksyalkilonikotynamidu do leczenia chorób układu sercowo-naczyniowego
PL1714647T3 (pl) Zastosowanie agomelatyny do wytwarzania leku do leczenia zaburzeń dwubiegunowych
IL182406A0 (en) Use of an anti-atherothrombotic compound in obtaining medicaments intended for the treatment of vascular disorders
ZA200708279B (en) Dermatological compositions and salts for the treatment of dermatological diseases
GB0618309D0 (en) Compositions and methods for the treatment of disease